Tiago Fernandes

Tiago Fernandes

Auto-generated profile, based on publicly available information

Tiago Fernandes

Departamento de Anestesia. Unidade Local de Saúde de Matosinhos. Hospital Pedro Hispano. Matosinhos. Grupo de Sustentabilidade Ambiental. Sociedade Portuguesa de Anestesiologia. Lisboa

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
JMJane Muret
Jane Muret
TFTiago David Fernandes
Tiago David Fernandes
HGHerwig Gerlach
Herwig Gerlach
GIGeorgina Imberger
Georgina Imberger
HJHenrik Jörnvall
Henrik Jörnvall
LWLucy Williams
Lucy Williams

1 December 2015 in Case Reports in Ophthalmology
Verified
Journal Article
Open access
PDF file
JLJosé Alberto Lemos
José Alberto Lemos
CTCarla Teixeira
Carla Teixeira
RCRui Carvalho
Rui Carvalho
TFTiago Fernandes
Tiago Fernandes
Background: Combined central retinal artery occlusion (CRAO) and central retinal vein occlusion (CRVO) is an uncommon retinal vascular disease which causes sudden visual acuity loss and is associated with poor prognosis and the development of severe complications. We report a very rare case of combined CRAO and CRVO in a patient with factor V Leiden (FVL) mutation (only 3 cases published). To our knowledge, this is the first case of combined CRAO and CRVO treated with hyperbaric oxygen therapy (HBOT). Case and Results: A 49-year-old woman presented with complaints of sudden loss of vision in her left eye (LE), with best corrected visual acuity (BCVA) of 1/20. A complete ophthalmic evaluation with fundus angiography showed combined CRAO and CRVO. The patient was urgently treated with HBOT (she completed a total of 9 sessions in 7 days), with marked visual acuity and angiographic improvement (BCVA of 10/10). Forty-five days later, she developed a new LE CRVO, and BCVA decreased to 5/10 and later to <1/20 because of significant macular edema. A detailed investigation showed an abnormal resistance to activated protein C, and a genetic study showed homozygosity for FVL mutation. The patient was submitted to 3 monthly injections of 1.25 mg bevacizumab. After 10 months, the patient is in a stable condition with BCVA of 6/10. Conclusions: Combined CRAO and CRVO in young adults should be investigated thoroughly for embolic sources, thrombophilic disorders and local ocular conditions. This is the first case of this severe disease that was treated with HBOT, and the visual result was very good.

11 June 2015 in BMJ Open
Verified
Journal Article
Open access
PDF file
IMIan L Millar
Ian L Millar
RMRosemary A McGinnes
Rosemary A McGinnes
OWOwen Williamson
Owen Williamson
FLFolke Lind
Folke Lind
KJKarl-Åke Jansson
Karl-Åke Jansson
PCPeter Cameron
Peter Cameron
Introduction Open fractures with significant soft tissue injury are associated with high rates of complications, such as non-union, infection, chronic pain and disability. Complications often require further inpatient care, and in many cases, multiple operations and prolonged rehabilitation. Use of hyperbaric oxygen therapy as an adjunct to standard orthopaedic trauma care has the potential to reduce the complications of musculoskeletal injury and thus improve outcomes. Two previous randomised trials have suggested some positive effect, but neither functional measures nor long-term outcomes were reported. Methods and analysis An international, multicentre, randomised, open-label, clinical trial. Patients with trauma with an acute open fracture of the tibia with severe soft tissue injury (Gustilo grade 3) and high risk of injury-related complications were recruited from participating major trauma hospitals with hyperbaric facilities. Patients were enrolled with the expectation of commencing 12 sessions of hyperbaric oxygen therapy within 48 h of injury. The primary outcome measure is the incidence of acute complications of the open fracture wound at 14 days. Other short-term outcome measures include amputation, need for fasciotomy, time until wound closure, breakdown of closed wounds, time until definitive orthopaedic fixation, number of operative procedures, intensive care stay and hospital stay. Long-term follow-up will continue for 2 years postinjury. Ethics and dissemination Ethics approval was given by The Alfred Health Human Ethics Committee (206/04) and the Monash University Human Research Ethics Committee (CF07/4208). Approval was also obtained from the institutional research ethics committee at each participating site. This study will make a significant contribution to the trauma literature and should answer the question of whether hyperbaric oxygen therapy can significantly improve outcomes in severe lower limb trauma. Collective study results will be published in international journals and presented at relevant conferences. Trial registration number Clinicaltrials.gov: NCT00264511; Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12607000559415.

12 March 2020 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
DFDaniel Ferreira
Daniel Ferreira
CSCarolina Soares
Carolina Soares
JTJoão Tavares-Ferreira
João Tavares-Ferreira
TFTiago Fernandes
Tiago Fernandes
RARui Araújo
Rui Araújo
Pedro CastroPedro Castro
Pedro Castro

1 July 2022 in Acta Medica Portuguesa
Verified
Journal Article
Open access
PDF file
CBCarlos Barbosa
Carlos Barbosa
TFTiago Fernandes
Tiago Fernandes
Environmental Sustainability in Healthcare Systems: The Role of Anaesthesiology

30 December 2014
Verified
Journal Article
Closed access
CMClara Magalhães
Clara Magalhães
NONuno Oliveira
Nuno Oliveira
GLGustavo Lopes
Gustavo Lopes
RNRoberto Nakamura
Roberto Nakamura
TFTiago Fernandes
Tiago Fernandes
MRManuel Rodrigues E Rodrigues
Manuel Rodrigues E Rodrigues